SI-BONE signals 2026 revenue of $231M-$233M as it plans Q4 launch of third breakthrough device (NASDAQ:SIBN)
· seekingalpha.com
SI-BONE (SIBN) Q2 2026 earnings call recap: 15% revenue growth, raised 2026 outlook, CMS/DRG reimbursement catalysts, and Q4 launch plans—read now.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...